Pharmacokinetics, Safety, Tolerability of TEV-48125 in Healthy Subjects After Administration of TEV-48125

Study Title
To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125
Teva Identifier
TV48125-PK-10078
ClinicalTrials.gov Identifier
NCT02673567
Study Status
Completed
Trial Condition(s)
Pharmacokinetics
Interventions
Drug: TEV-48125 - 1 | Drug: TEV-48125 - 2 | Drug: TEV-48125 - 3 | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 55 Years
Trial Duration
March 31, 2016 - February 10, 2017
Phase
Phase 1

Study Type

Interventional